Search research articles
Contact Us
Filters
Showing results (1201-1210 of 1,259) with videos related to
Page
of 126
Sort By:
Journal of Medicinal Chemistry
|
December 28, 2020
Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195)
Hengmiao Cheng, Suvi T M Orr, Simon Bailey, et al.
Pharmacological Reviews
|
August 16, 2023
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023
Thomas P Burris, Ian Mitchelle S de Vera, Isabelle Cote, et al.
British Journal of Cancer
|
March 29, 2017
Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium
Suzanne C Dixon, Christina M Nagle, Nicolas Wentzensen, et al.
Journal of Medicinal Chemistry
|
March 14, 2017
Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR
Simon Planken, Douglas C Behenna, Sajiv K Nair, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 25, 2023
Identification of small-molecule protein-protein interaction inhibitors for NKG2D
Aaron A Thompson, Michael B Harbut, Pei-Pei Kung, et al.
Blood
|
June 21, 2024
Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemias
Min Chul Kwon, Jan Willem Thuring, Olivier Querolle, et al.
Ecology
|
August 6, 2019
FragSAD: A database of diversity and species abundance distributions from habitat fragments
Jonathan M Chase, Mario Liebergesell, Alban Sagouis, et al.
Journal of Medicinal Chemistry
|
January 18, 2014
Design of potent and selective inhibitors to overcome clinical anaplastic lymphoma kinase mutations resistant to crizotinib
Qinhua Huang, Ted W Johnson, Simon Bailey, et al.
Cancer
|
March 6, 2019
Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference
Robert C Bast, Ursula A Matulonis, Anil K Sood, et al.
Cancer Research
|
April 6, 2007
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer
Simon A Gayther, Honglin Song, Susan J Ramus, et al.
Page
of 126
Search research articles
Search
Showing results (1201-1210 of 1,259) with videos related to
Sort By:
Page
of 126
Journal of Medicinal Chemistry
|
December 28, 2020
Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195)
Hengmiao Cheng, Suvi T M Orr, Simon Bailey, et al.
Pharmacological Reviews
|
August 16, 2023
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023
Thomas P Burris, Ian Mitchelle S de Vera, Isabelle Cote, et al.
British Journal of Cancer
|
March 29, 2017
Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium
Suzanne C Dixon, Christina M Nagle, Nicolas Wentzensen, et al.
Journal of Medicinal Chemistry
|
March 14, 2017
Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR
Simon Planken, Douglas C Behenna, Sajiv K Nair, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 25, 2023
Identification of small-molecule protein-protein interaction inhibitors for NKG2D
Aaron A Thompson, Michael B Harbut, Pei-Pei Kung, et al.
Blood
|
June 21, 2024
Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemias
Min Chul Kwon, Jan Willem Thuring, Olivier Querolle, et al.
Ecology
|
August 6, 2019
FragSAD: A database of diversity and species abundance distributions from habitat fragments
Jonathan M Chase, Mario Liebergesell, Alban Sagouis, et al.
Journal of Medicinal Chemistry
|
January 18, 2014
Design of potent and selective inhibitors to overcome clinical anaplastic lymphoma kinase mutations resistant to crizotinib
Qinhua Huang, Ted W Johnson, Simon Bailey, et al.
Cancer
|
March 6, 2019
Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference
Robert C Bast, Ursula A Matulonis, Anil K Sood, et al.
Cancer Research
|
April 6, 2007
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer
Simon A Gayther, Honglin Song, Susan J Ramus, et al.
Page
of 126